Skip to main content
Premium Trial:

Request an Annual Quote

Genometrix Appoints Chief Scientific Officer

Premium

THE WOODLANDS, Texas--Michael Hogan, a professor in the molecular physiology and biophysics department at Baylor College of Medicine, has been appointed chief scientific officer at Genometrix, a developer of microarray devices.

Hogan has served as Genometrix's scientific advisor since its founding in 1993, and is an advisor to the National Institutes of Health in the fields of chemical carcinogens, pharmaceutical design, and DNA technologies. He heads a collaborative project with Genometrix, Baylor College of Medicine, the Univer sity of Texas MD Anderson Cancer Center, and the National Cancer Institute to develop microarray-based systems for cancer research, assessment, and diagnosis.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.